Johny Nicolas

27PUBLICATIONS
73CO-AUTHORS
PharmacogenomicsCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 01, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impact.

|Oct 22, 2025
Impact of Remnant Cholesterol on Cardiovascular Outcomes in Non-Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.

Nicholas Pitaro, Benjamin Bay, Samantha Sartori

|May 15, 2025
Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE-TAVI AF Trial.

George D Dangas, Martin Unverdorben, Johny Nicolas

|Mar 20, 2025
Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular disease.

Francesca Maria Di Muro, Birgit Vogel, Samantha Sartori

|May 21, 2024
Incidence and Impact of Contrast-Associated Acute Kidney Injury in Patients With High-Bleeding Risk Undergoing Percutaneous Coronary Intervention.

Johny Nicolas, Nicholas Pitaro, Samantha Sartori

|Apr 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.

Daniel Feldman, Davide Cao, Samantha Sartori

Pageof 5

Frequent Collaborators

14 joint publications

George Dangas

12 joint publications

Roxana Mehran

11 joint publications

Samantha Sartori

9 joint publications

Mauro Chiarito